Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Dr. Vivienne Rebel reports on a study of the relationship between gene mutations and overall survival after stem cell transplant

    ... survival after transplantation for patients with this mutation was only 4.6 months and none lived much beyond 4 years.  Thus, it ... has minimal, if any, benefits for MDS patients with a TP53 mutation.  The authors conclude that if a blood-stem cell transplantation is ...

    Research Review last updated 05/02/2016 - 9:16am.

  2. Identification of genetic abnormalities in MDS patients that may lead to a better diagnosis and treatment strategy of MDS patients

    ... (nearly twice as high) in the group of patients with a mutation in the TET2 gene in their blood cells compared to the group who did not have this mutation.  Mutations that can predict therapeutic outcome are of importance ...

    Research Review last updated 05/02/2016 - 9:23am.

  3. Daria Babushok, MD, PhD

    ... progeny of a single cell that initially acquired a given mutation . This phenomenon, where a large fraction of blood cells originate ...

    Bio last updated 03/11/2016 - 1:41pm.

  4. Eric Padron, M.D.

    ... Other work Dr. Padron is pursuing involves the SRSF2 mutation that can occur in MDS and may be related to progression to other ...

    Bio last updated 03/11/2016 - 1:41pm.

  5. Rosannah Cameron, PhD.

    ... blood-forming stem cells, we study zebrafish that have a mutation in a spliceosomal gene commonly mutated in MDS (sf3b1). The aim of ...

    Bio last updated 03/11/2016 - 1:41pm.

  6. Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

    ... intermediate or high cytogenetic risk factors or flt3 mutation . Patients with relapsed disease. Patients with primary induction ...

    Clinical Trial last updated 06/06/2016 - 12:41pm.

  7. Detection of Recurrent Mutations by Pooled Targeted Next-Generation Sequencing in MDS Patients Prior to Treatment with Hypomethylating Agents or Stem Cell Transplantation

    ... (14%) genes.   In Cohort 2, 37% of patients had a mutation in a splicing factor gene ( SF3B1 , U2AF1 , SRSF2 , or ... of patients in Cohort 2 than Cohort 1 had a genetic mutation associated with a poor prognosis (especially TP53 ). Also, fewer ...

    Research Review last updated 05/02/2016 - 9:26am.

  8. Zhe Yang, PhD

    ... in MDS. The exciting new discovery of frequent Tet2 mutation in a wide range of myeloid malignancies including ...

    Grant Recipient last updated 12/06/2013 - 4:25pm.

  9. Mridul Mukherji, DPhil

    ... (MDS). Results from recent studies have established that mutation in the TET2 tumor suppressor gene is one of the fundamental causes ...

    Grant Recipient last updated 10/01/2012 - 10:46am.

  10. Pathogenesis of MDS: An overview of molecular and non-molecular aspects of the disease

    ... that 78% of MDS patients carry at least one somatic mutation .  Knowledge of these mutations may help in diagnosing patients as ...

    Research Review last updated 05/02/2016 - 9:14am.